Ceribell, INC. 8-K Filing
Ticker: CBLL · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1861107
| Field | Detail |
|---|---|
| Company | Ceribell, INC. (CBLL) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Ceribell, INC. (ticker: CBLL) to the SEC on Jan 13, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (nge on which registered Common stock, $0.001 par value per share CBLL Nasdaq Glo).
How long is this filing?
Ceribell, INC.'s 8-K filing is 2 pages with approximately 493 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 493 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2025-01-13 10:30:14
Key Financial Figures
- $0.001 — nge on which registered Common stock, $0.001 par value per share CBLL Nasdaq Glo
Filing Documents
- cbll-20250113.htm (8-K) — 48KB
- cbll-ex99_1.htm (EX-99.1) — 30KB
- cbll-ex99_1s1.jpg (GRAPHIC) — 129KB
- cbll-ex99_1s2.jpg (GRAPHIC) — 777KB
- cbll-ex99_1s3.jpg (GRAPHIC) — 325KB
- cbll-ex99_1s4.jpg (GRAPHIC) — 270KB
- cbll-ex99_1s5.jpg (GRAPHIC) — 376KB
- cbll-ex99_1s6.jpg (GRAPHIC) — 214KB
- cbll-ex99_1s7.jpg (GRAPHIC) — 358KB
- cbll-ex99_1s8.jpg (GRAPHIC) — 319KB
- cbll-ex99_1s9.jpg (GRAPHIC) — 314KB
- cbll-ex99_1s10.jpg (GRAPHIC) — 319KB
- cbll-ex99_1s11.jpg (GRAPHIC) — 273KB
- cbll-ex99_1s12.jpg (GRAPHIC) — 261KB
- cbll-ex99_1s13.jpg (GRAPHIC) — 279KB
- cbll-ex99_1s14.jpg (GRAPHIC) — 398KB
- cbll-ex99_1s15.jpg (GRAPHIC) — 295KB
- cbll-ex99_1s16.jpg (GRAPHIC) — 403KB
- cbll-ex99_1s17.jpg (GRAPHIC) — 327KB
- cbll-ex99_1s18.jpg (GRAPHIC) — 266KB
- cbll-ex99_1s19.jpg (GRAPHIC) — 227KB
- cbll-ex99_1s20.jpg (GRAPHIC) — 297KB
- cbll-ex99_1s21.jpg (GRAPHIC) — 256KB
- cbll-ex99_1s22.jpg (GRAPHIC) — 232KB
- cbll-ex99_1s23.jpg (GRAPHIC) — 324KB
- cbll-ex99_1s24.jpg (GRAPHIC) — 309KB
- cbll-ex99_1s25.jpg (GRAPHIC) — 287KB
- cbll-ex99_1s26.jpg (GRAPHIC) — 302KB
- cbll-ex99_1s27.jpg (GRAPHIC) — 344KB
- cbll-ex99_1s28.jpg (GRAPHIC) — 123KB
- 0000950170-25-004633.txt ( ) — 12049KB
- cbll-20250113.xsd (EX-101.SCH) — 24KB
- cbll-20250113_htm.xml (XML) — 5KB
01
Item 7.01 Regulation FD Disclosure. Ceribell, Inc. is scheduled to present at the 2025 J.P. Morgan Annual Healthcare Conference on January 13, 2025. A copy of this presentation is attached as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed' for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. Exhibit No. Description 99.1 Presentation Slides made available on January 13, 2025. 104 Cover Page Interactive Data File, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CERIBELL, INC. Date: January 13, 2025 By: /s/ Scott Blumberg Scott Blumberg Chief Financial Officer